Biocryst Pharmaceuticals Inc operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Biocryst Pharmaceuticals Inc with three other
companies in this sector in UNITED STATES :
Twist Bioscience Corp
sales of $54.39 million
of which 40%
was Industrial chemicals),
Protalix Biotherapeutics Inc
of which 100%
was Biotherapeutic Products), and
Apollo Endosurgery Inc
of which 56%
was Endo bariatric-ESS).
Biocryst Pharmaceuticals Inc reported sales of $48.84 million
December of 2019.
increase of 136.5%
versus 2018, when the company's sales were $20.65 million.